Aneurysma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Sub-study A. scheduled endovascular aneurysm repair using the Gore IBE device. • Sub-study B. Patients that have been treated with an iliac branched device in the past (Oct 2006-May 2018) in conjunction with either a dedicated IIA component (Gore IBE device) or non-dedicated IIA component (Cook IBD) and who are scheduled for follow-up imaging within the period July 2016-December 2018.
Exclusion criteria
Exclusion criteria: No specific exclusion criteria. Patients will be treated according to the hospital*s standard practice.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To compare the mobility of the hypogastic artery during the cardiac cycle before and after implantation of the Gore IBE device (Sub-study A). 2. To quantitatively characterize the displacement during the cardiac cycle on an implanted iliac branched endograft in conjunction with a non-dedicated n balloon expandable IIA component (Cook IBD with Advanta V12 or Fluency) with those in conjunction with a dedicated self expandable Internal Iliac cComponent (Gore IBE device). (Sub-study B). | — |
Secondary
| Measure | Time frame |
|---|---|
| Endpoints of the study will be; a. Displacement and angulation of the IIA component during the cardiac cycle compared to the native outflow vessel (Sub-study A) b. Displacement and angulation of the IIA component during the cardiac cycle compared to the main Gore IBE device/Cook IBD (Sub-study B) c. Tortuosity of the IIA component, defined as the difference between the highest angles of the central luminal line of the IIA component during the various phases. | — |
Countries
The Netherlands